Financials
Financial year 2025
ISeeCure from Beauvechain, company number BE0662668168, closed financial year 2025 with a result of € 6,480 after tax. For that financial year ISeeCure recorded a gross margin of € 16,498 and equity of € 61,084. Compared with financial year 2024, the result moved from € 24,626 to € 6,480. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2025.
€ 61,084
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,480
▼ 74% vs 2024
Profit after tax over the fiscal year.
€ 55,766
▲ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 47,584.
People and assets in 2025
€ 133
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,776
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 237
▼ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,359
▲ 6% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 2,223 | € 2,052 | € 41,704 | € 16,498 | ▼ 60% |
| Profit after taxes | € -5,367 | € -7,612 | € 24,626 | € 6,480 | ▼ 74% |
| Equity | € 38,261 | € 30,649 | € 55,274 | € 61,084 | ▲ 11% |
| Total debts | € 9,672 | € 16,786 | € 15,641 | € 16,596 | ▲ 6% |
| Cash | € 16,816 | € 21,247 | € 42,725 | € 55,766 | ▲ 31% |
| Retained profit | € 24,761 | € 17,149 | € 41,774 | € 47,584 | ▲ 14% |
| Balance sheet total | € 47,933 | € 47,434 | € 70,915 | € 77,681 | ▲ 10% |
Key figures of ISeeCure, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to ISeeCure?
What happened at ISeeCure in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,480 (▼ 74% vs 2024). Source: NBB ↗
- Marie -Claire RENNESON became a director. NBB
- François DEVIGNE stepped down as director. NBB
- François DEVIGNE became a director. NBB
- Paul DEVIGNE stepped down as director. NBB
- Cédric DEVIGNE became a director. NBB
- Paul DEVIGNE became a director. NBB
- New establishment in Beauvechain. KBO
In short
From € 5,367 loss in 2022 to € 6,480 profit in 2025.
Paid € 19,728 in corporate taxes since 2022.
Best year ever: 2024, with € 24,626 profit.
Management
Behind ISeeCure are Cédric DEVIGNE and Marie -Claire RENNESON.
Directors
According to the 2025 annual accounts
Cédric DEVIGNE
Director
since 2016
Marie -Claire RENNESON
Director
since 2024
François DEVIGNE
Director
since 2021 · until 2024
Paul DEVIGNE
Manager
since 2016 · until 2021
Establishments
Establishment units
Physical locations of this company
Rue de Valduc,H.-M. 2
1320 Beauvechain
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0662.668.168
- VAT number
- BE 0662.668.168
- Registered office
- Rue de Valduc,H.-M. 2, 1320 Beauvechain
- Names & denominations
- ISeeCure
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 September 2016
- Peppol
- Active · Active since 18 Sept 2026
- Activities · NACE
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Overige diensten op het gebied van informatietechnologie en computer
Overige vormen van onderwijs
Gegevensverwerking, webhosting en aanverwante activiteiten